Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis - Wikidata - wikimedia - TriplyDB

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

http://www.wikidata.org/entity/Q36986669

about

Quality of outcome reporting in phase II studies in pulmonary tuberculosis Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis Tuberculosis therapy for 2016 and beyond.Recent advances in tuberculosis: New drugs and treatment regimens.Understanding pharmacokinetics to improve tuberculosis treatment outcome.Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis.Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.Linezolid for treatment of chronic extensively drug-resistant tuberculosis.The role of delamanid in the treatment of drug-resistant tuberculosis.Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis Current development and future prospects in chemotherapy of tuberculosis Smoking and 2-month culture conversion during anti-tuberculosis treatment World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.Update in tuberculosis 2008.Management of multidrug-resistant tuberculosis: an update.Emerging drugs for the treatment of tuberculosis.Drug repositioning in the treatment of malaria and TB.New treatment options for multidrug-resistant tuberculosis.Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment.The early bactericidal activity of antituberculosis drugs.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Linezolid: a promising option in the treatment of Gram-positives.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs.Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.

P2860

Q26777160-766B1050-A275-4BA3-B539-D3EE3136F4CE Q28537839-D18D45C4-3797-4E28-BF4A-4138FB136C24 Q30248788-5DD84B25-02F9-4F56-A571-FB30796673BF Q30360811-5DB0E7BA-F0F6-42E5-BEE6-CA42582EC686 Q30411703-40E443C5-29A8-43DD-A7D7-1F30BD2C87EB Q30419537-D5BA2A96-0C96-472D-8F03-9AAE927CD76E Q33434791-FAB79D22-AD18-4DE7-AEEE-85A88B107F8B Q33798173-2F2029B4-A864-44F3-AD8E-9669E3D7EA0C Q33798492-AF02BFAF-040F-4FCB-A8FE-153F81A753D5 Q34299173-523BE085-7D1D-46AB-B23A-770955DF6995 Q34644127-8427587B-C272-4B19-A4B4-8C77AB759E23 Q35624245-F5716618-1AE3-452E-824E-C2F001430B37 Q35687128-099D271D-0FC5-4BF9-A0DA-5373224E4106 Q35705874-E8971F5A-391E-4446-A0BA-5BCEE99452CA Q35835697-A168E636-49F1-45E0-AAD0-5C1223C3C2AE Q36957270-BC995174-8C42-4C60-968D-9DFFFB3BE6BA Q37333092-3C74CF50-A365-47C6-BF6E-237F5463C37B Q37398528-D6E0CEFA-5038-4F36-8AFF-3015F496FFE6 Q37730293-C8B02E88-57FE-42AA-A33F-A86F1357255A Q37792105-0DC8D167-D2A8-4C15-A021-38F8C73F4FA4 Q37924298-DA883395-C78C-424C-B6D7-92CEEE2F8013 Q38024041-DD3C0662-46F6-4C2E-AC39-0F51D916A581 Q38040155-F755A04B-ED78-490F-9B03-FCB8D1A835EB Q38044744-70521CEC-236A-4EFC-B499-7DBC7F5D6F73 Q38176039-C3C0261E-3CAF-49E5-A5F3-304D319E008D Q38929509-FC4846AD-F4EF-43E3-AF10-5AF0999F5122 Q39044932-7A7630E1-8036-4E00-9075-6A091464B308 Q39967041-B72E1B43-4413-4FDA-9520-FBD82F481D54 Q40211670-2BBA984C-83BE-44AD-BC05-015FC654BC64 Q42363645-303C1A8C-939C-45BC-9025-081B9808CA0C Q43138250-763279C6-F3B4-4155-8D91-615C01BBB4DD Q45972156-261BA504-BBAC-410E-A24A-09CD771D1DDA Q47332682-890AE951-8C90-47E0-B373-D4E50B7AC8E2 Q53698038-5AB551D8-6B58-4529-BA85-FA26DF3F0E27

P2860

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

http://www.wikidata.org/entity/Q36986669

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

@en

type

label

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

@en

prefLabel

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

@en

P1433

Q36986669-98236446-9FDD-47C4-ABC8-01A8A3D13B5F

P1476

Q36986669-CC1AFAB1-EB6C-4999-8DB6-78129007CF62

P2093

Q36986669-06C3EC23-CC80-4D4F-A701-35F317A31095

Q36986669-1E3F01E2-9BDC-4CB6-8578-6468E6AF306C

Q36986669-3CDF09D6-F506-4F56-A988-8F0180DB1E25

Q36986669-52DB8279-344D-4AB0-B699-1461D3F619AB

Q36986669-7CE81F15-9EAC-435A-A888-8A159B3AC715

Q36986669-94E03A74-738B-4299-AD09-CB9CE75691EC

Q36986669-A3EED392-B72C-4747-B10E-842D4D4493E9

Q36986669-AAFA4BD6-E42C-4980-8EEE-F28D06E31750

Q36986669-B15EA3F0-AD2A-4B18-BAC4-BC829D7C2A8F

Q36986669-EC77DE9C-C453-4986-A07A-2D256A670259

P2860

Q36986669-0611BAF7-CF56-475B-814D-36822E989DD7

Q36986669-097D17D3-E319-40E1-BD22-86D717E9D57B

Q36986669-0BB0CCC4-3748-45E8-AD54-535966813EA2

Q36986669-17DB9222-2C54-4E66-98D0-4524468CE36E

Q36986669-1B91C540-105A-411B-BBBE-723866CB0201

Q36986669-20E9BDFA-C680-4215-8F82-E4596E079A61

Q36986669-29F4C2ED-5238-4474-9DAB-5770CCA27694

Q36986669-2C3A40F7-534D-4796-BDEF-A60CCB005A88

Q36986669-3D8ABABB-BF34-487E-8F9B-F023BD6F10E7

Q36986669-4176A6FB-B5CD-4EED-9645-00A6C85542D6

P304

Q36986669-27C82F42-0B86-4562-ABC6-32939FCFB7B4

P31

Q36986669-7B46B3EE-3F97-4AE7-891F-6ABC8CCC9760

P356

Q36986669-FC0B1F03-C029-4F7C-8F88-2568CD426468

P407

Q36986669-4789360A-5058-4694-8D3E-C2FAEC23398B

P433

Q36986669-18130FE6-F14A-4702-86DE-EEF68FF82335

P478

Q36986669-2E9209F2-33A2-46B7-97F7-15E83B4C08ED

P50

Q36986669-E98365B2-DC1A-47BF-A59C-EFB39C4A3B1E

P577

Q36986669-4727F5DC-52CA-41FF-BF9D-AADA6245A4D8

P698

Q36986669-B5A13FD7-B867-433B-9015-C31E1A089A2E

P921

Q36986669-ED352777-C912-42C9-BE0B-2313075C0633

P932

Q36986669-15319F53-9157-4E85-A550-4780A4F4297E

P356

RCCM.200806-892OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

@en

P2093

Bryan McGee

http://www.w3.org/2001/XMLSchema#string

Charles A Peloquin

http://www.w3.org/2001/XMLSchema#string

David Jamil Hadad

http://www.w3.org/2001/XMLSchema#string

Denise F Johnson

http://www.w3.org/2001/XMLSchema#string

John L Johnson

http://www.w3.org/2001/XMLSchema#string

Kathleen Eisenach

http://www.w3.org/2001/XMLSchema#string

Lucilia Pereira Dutra Molino

http://www.w3.org/2001/XMLSchema#string

Moises Palaci

http://www.w3.org/2001/XMLSchema#string

Reynaldo Dietze

http://www.w3.org/2001/XMLSchema#string

Sara M Debanne

http://www.w3.org/2001/XMLSchema#string

P2860

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis

Mechanism of action of the oxazolidinone antibacterial agents

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This st

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

Intrapulmonary pharmacokinetics of linezolid

Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.

Linezolid for the treatment of multidrug-resistant tuberculosis.

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

P304

1180-1185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200806-892OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Ethel Leonor Noia Maciel

P577

2008-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18787216

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

2588492

http://www.w3.org/2001/XMLSchema#string